Having trouble accessing articles? Reset your cache.

PEGPH20: Phase Ib/II data

Data from 24 evaluable patients with previously untreated stage IV metastatic pancreatic cancer in the open-label, dose-escalation Phase Ib portion of a double-blind, U.S. and Russian Phase I/II

Read the full 285 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE